The following is a summary of the Materialise NV (MTLS) Q1 2024 Earnings Call Transcript:
Financial Performance:
Materialise NV's total Q1 2024 revenue slightly decreased by 3.4% to €63.6 million due to weak prototyping demand and the shift to cloud and subscription-based business model in the Software segment.
Gross margin, however, increased to 56.5% from 55.9% in the same period the previous year.
Adjusted EBIT amounted to €2.7 million, representing 4.2% of revenue while net profit was stable at €3.6 million or €0.06 per share.
The company's net cash position at the end of Q1 2024 was €69.2 million, an increase of €6 million from the start of the quarter.
Business Progress:
Materialise NV made significant progress on its strategic priorities, launching new technologies, and extending its reach into new markets and segments.
Growth was seen in the market adoption of personalized medical cases and developments were made in new software solutions.
The move from prototyping to larger certified manufacturing projects is underway and they entered the trauma market with short lead times in the U.S. - expected to be a key growth driver.
They are focusing on untapped markets and investing in developing offerings for end-use product manufacturing, especially in software units. In addition, their investment in the CO-AM platform, which helps customers scale in the production of end-use products, continues to grow.
More details: Materialise IR
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.